Detalles de la búsqueda
1.
Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer.
Br J Cancer;
125(1): 38-47, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33828257
2.
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
Cancer;
125(22): 3974-3984, 2019 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31318460
3.
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.
J Clin Oncol;
35(2): 141-148, 2017 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28056202
Resultados
1 -
3
de 3
1
Próxima >
>>